August 1, 2011

A critical eye on Infuse use studies

By: OR Manager
PDF
Share
A leading spine journal is casting a critical eye on industry-supported research that has led to widespread use of Medtronic’s controversial bone growth product Infuse. The June 2011 issue of Spine Journal carries a strongly worded editorial about the trial…
Live chat by BoldChat